Literature DB >> 2619749

The anticoagulant activity of Malayan cobra (Naja naja sputatrix) venom and venom phospholipase A2 enzymes.

N H Tan1, A Arunmozhiarasi.   

Abstract

Malayan cobra (Naja naja sputatrix) venom was found to exhibit an in vitro anticoagulant activity that was much stronger than most common cobra (genus Naja) venoms. The most potent anticoagulants of the venom are two lethal phospholipase A2 enzymes with pI's of 6.15 and 6.20, respectively. The anticoagulant activity of the venom is due to the synergistic effect of the venom phospholipase A2 enzymes and polypeptide anticoagulants. Bromophenacylation of the two phospholipase A2 enzymes reduced their enzymatic activity with a concomitant drop in both the lethal and anticoagulant activities.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2619749

Source DB:  PubMed          Journal:  Biochem Int        ISSN: 0158-5231


  5 in total

1.  Carbon monoxide inhibits the anticoagulant activity of Mojave rattlesnake venoms type A and B.

Authors:  Vance G Nielsen
Journal:  J Thromb Thrombolysis       Date:  2019-08       Impact factor: 2.300

2.  Multiple mechanisms underlying neuroprotection by secretory phospholipase A2 preconditioning in a surgically induced brain injury rat model.

Authors:  Yuechun Wang; Prativa Sherchan; Lei Huang; Onat Akyol; Devin W McBride; John H Zhang
Journal:  Exp Neurol       Date:  2017-10-24       Impact factor: 5.330

3.  Carbon monoxide inhibits the anticoagulant activity of phospholipase A2 purified from Crotalus adamanteus venom.

Authors:  Vance G Nielsen
Journal:  J Thromb Thrombolysis       Date:  2019-01       Impact factor: 2.300

4.  Naja sputatrix Venom Preconditioning Attenuates Neuroinflammation in a Rat Model of Surgical Brain Injury via PLA2/5-LOX/LTB4 Cascade Activation.

Authors:  Yuechun Wang; Prativa Sherchan; Lei Huang; Onat Akyol; Devin W McBride; John H Zhang
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

5.  A secretory phospholipase A2-mediated neuroprotection and anti-apoptosis.

Authors:  Arunmozhiarasi Armugam; Charmian D N Cher; KaiYing Lim; Dawn C I Koh; David W Howells; Kandiah Jeyaseelan
Journal:  BMC Neurosci       Date:  2009-09-23       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.